{
    "2020-07-22": [
        [
            {
                "time": "2020-07-22",
                "orginal_text": "基金持仓分析：权益仓位提高 增配科技、消费、医药",
                "features": {
                    "keywords": [
                        "基金",
                        "持仓",
                        "权益",
                        "科技",
                        "消费",
                        "医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "消费",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "药明康德（603259）：中报业绩超预期 长期发展潜力充足",
                "features": {
                    "keywords": [
                        "药明康德",
                        "中报",
                        "业绩",
                        "超预期",
                        "长期发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "125家药企半年报预告出炉，康泰生物Q2环比100倍增长，药明康德、华海药业",
                "features": {
                    "keywords": [
                        "药企",
                        "半年报",
                        "康泰生物",
                        "药明康德",
                        "华海药业",
                        "增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "牛股频频出没！高瓴押注CRO背后的考量",
                "features": {
                    "keywords": [
                        "牛股",
                        "高瓴",
                        "CRO",
                        "押注"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "药明康德（603259）：核心业务二季度超预期增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "核心业务",
                        "二季度",
                        "超预期",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "招商香港：产能持续扩张将巩固药明康德（02359-HK）长期的增长前景重申买入评级",
                "features": {
                    "keywords": [
                        "招商香港",
                        "产能扩张",
                        "药明康德",
                        "增长前景",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "药明康德的AB面：业绩大增股价走高，高管却逢高套现，股东二度减持抛近25亿减持计划 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩",
                        "股价",
                        "高管",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "制药股普遍获资金青睐 石药集团上扬2%联邦制药飙11%",
                "features": {
                    "keywords": [
                        "制药股",
                        "石药集团",
                        "联邦制药",
                        "资金青睐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "第三家!“A+H”两地上市的CRO企业哪家强？",
                "features": {
                    "keywords": [
                        "A+H",
                        "CRO",
                        "上市",
                        "企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "多款新冠疫苗临床数据出炉，T细胞免疫反应为何成为关注热点？",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "临床数据",
                        "T细胞",
                        "免疫反应"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "FDA新增II类器械510（k）豁免，510（k）审评通道现代化迈出步伐",
                "features": {
                    "keywords": [
                        "FDA",
                        "II类器械",
                        "510(k)",
                        "豁免",
                        "审评通道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "上市公司正负面新闻2020年7月22日星期三",
                "features": {
                    "keywords": [
                        "上市公司",
                        "正负面新闻"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-22",
                "orginal_text": "药明康德（02359-HK）基金股东拟减持 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "基金股东",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}